Package 72162-1347-3

{"route": ["SUBLINGUAL"], "spl_id": "0163f07d-4db5-4929-a2b7-27165bede377", "openfda": {"unii": ["56W8MW3EN1", "5Q187997EE"], "rxcui": ["351267"], "spl_set_id": ["fe023dbf-e165-4b7f-a211-bd14696f1e2c"], "manufacturer_name": ["Bryant Ranch Prepack"]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET in 1 BOTTLE, PLASTIC (72162-1347-3)", "package_ndc": "72162-1347-3", "marketing_start_date": "20240312"}], "brand_name": "Buprenorphine and Naloxone", "product_id": "72162-1347_0163f07d-4db5-4929-a2b7-27165bede377", "dosage_form": "TABLET", "pharm_class": ["Opioid Antagonist [EPC]", "Opioid Antagonists [MoA]", "Partial Opioid Agonist [EPC]", "Partial Opioid Agonists [MoA]"], "product_ndc": "72162-1347", "dea_schedule": "CIII", "generic_name": "Buprenorphine and Naloxone", "labeler_name": "Bryant Ranch Prepack", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Buprenorphine and Naloxone", "active_ingredients": [{"name": "BUPRENORPHINE HYDROCHLORIDE", "strength": "8 mg/1"}, {"name": "NALOXONE HYDROCHLORIDE DIHYDRATE", "strength": "2 mg/1"}], "application_number": "ANDA205601", "marketing_category": "ANDA", "marketing_start_date": "20200413", "listing_expiration_date": "20261231"}